Accelerant Holdings
NYSE:ARXInsurance - Brokers
-$0.33 today
- Market cap
- $4.33B
- Beta
- -0.77
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$6.15
Volume 0.82M
Average 1.42M
ARX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Accelerant HoldingsNYSE: ARX
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How ARX compares with its peers on the latest reported figures
- ARX's LTM Sep 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for ARX, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ARXAccelerant Holdings | LTM Sep 2026 | $0 | — | — | 0.0% |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ARX) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for ARX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 103.2M | 213.1M | 329.7M | 597.7M | 879.5M |
| Cost of Revenue | 39.7M | 134.5M | 130.2M | 248.7M | 284.3M |
| Gross Profit | 63.5M | 78.6M | 199.5M | 349M | 595.2M |
| Gross Margin | 61.5% | 36.9% | 60.5% | 58.4% | 67.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 65.5M | 121.2M | 198.7M | 262.4M | 428.1M |
| Operating Expenses | 83.5M | 162.9M | 243.4M | 317M | 1.92B |
| Depreciation & Amortization | 1.6M | 5.8M | 14.5M | 26.6M | 35.2M |
| EBITDA | (15.5M) | (74.3M) | (14.3M) | 91M | (1.22B) |
| EBITDA Margin | -15.0% | -34.9% | -4.3% | 15.2% | -138.5% |
| Operating Income | (20M) | (84.3M) | (43.9M) | 32M | (1.32B) |
| Operating Margin | -19.4% | -39.6% | -13.3% | 5.4% | -150.3% |
| Interest Income | 200K | 2M | 20.9M | 50.5M | 79M |
| Interest Expense | 2.9M | 4.2M | 15.1M | 32.4M | 69M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | (20M) | (84.3M) | (43.9M) | 32M | (1.32B) |
| Pre-Tax Margin | -19.4% | -39.6% | -13.3% | 5.4% | -150.3% |
| Income Tax Expense | 4.3M | 11.3M | 20.2M | 9.1M | 23.3M |
| Net Income | (21.5M) | (91.7M) | (48.8M) | 27.2M | (1.35B) |
| Net Margin | -20.8% | -43.0% | -14.8% | 4.6% | -154.0% |
| EPS (Basic) | (0.13) | (0.55) | (0.30) | 0.17 | (7.49) |
| EPS (Diluted) | (0.10) | (0.55) | (0.23) | 0.13 | (7.49) |
| Weighted Avg Shares | 162.5M | 165.6M | 162.5M | 162.5M | 190.26M |
| Weighted Avg Shares (Diluted) | 216.67M | 165.6M | 216.67M | 216.67M | 190.26M |
Accelerant Holdings
NYSE:ARX
Intrinsic Alpha fair value
Locked
Current Price
$19.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.